Abiraterone acetate and Swallowing difficulty - a phase IV clinical study of FDA data

Summary:

Swallowing difficulty is reported as a side effect among people who take Abiraterone acetate (abiraterone acetate), especially for people who are male, 60+ old, have been taking the drug for < 1 month also take Eligard, and have Prostate cancer metastatic.

The phase IV clinical study analyzes which people have Swallowing difficulty when taking Abiraterone acetate. It is created by eHealthMe based on reports of 6,278 people who have side effects when taking Abiraterone acetate from the FDA, and is updated regularly.

What is Abiraterone acetate?

Abiraterone acetate has active ingredients of abiraterone acetate. eHealthMe is studying from 6,297 Abiraterone acetate users. Check the latest studies of Abiraterone acetate.

What is Swallowing difficulty?

Swallowing difficulty is found to be associated with 2,402 drugs and 3,352 conditions by eHealthMe. Check the latest studies of Swallowing difficulty.

On Jul, 28, 2026

6,278 people reported to have side effects when taking Abiraterone acetate.
Among them, 21 people (0.33%) have Swallowing difficulty.

Could Abiraterone acetate cause Swallowing difficulty?

Among these 21 people:

How long have people been on Abiraterone acetate when they have Swallowing difficulty? *

What is the gender of people who have Swallowing difficulty when taking Abiraterone acetate? *

female: 0.0 %
male: 100 %

What is the age of people who have Swallowing difficulty when taking Abiraterone acetate? *

What are other drugs people take besides Abiraterone acetate? *

What are other side effects people have besides Swallowing difficulty? *

Anaemia (lack of blood): 4 people, 19.05%
Hypokalemia (low potassium): 3 people, 14.29%
Lumbar Vertebral Fracture: 3 people, 14.29%
Paraneoplastic Dermatomyositis (inflammation of the skin and underlying muscle tissue, typically occurring as an autoimmune condition or associated with internal cancer): 3 people, 14.29%
Disease Recurrence: 3 people, 14.29%
Fever: 3 people, 14.29%
Prostatic Specific Antigen Increased: 3 people, 14.29%
Gastric Ulcer (stomach ulcer): 3 people, 14.29%
Oesophageal Achalasia (difficulty swallowing, food sticking in the oesophagus): 3 people, 14.29%
Back Pain: 3 people, 14.29%

What are the existing conditions these people have? *

Prostate Cancer Metastatic: 14 people, 66.67%
Prostate Cancer: 8 people, 38.10%
Pain: 4 people, 19.05%
Nasopharyngitis (inflammation of the nasopharynx): 2 people, 9.52%
Bone Pain: 2 people, 9.52%
Viral Upper Respiratory Tract Infection: 1 person, 4.76%
Anaemia (lack of blood): 1 person, 4.76%
Constipation: 1 person, 4.76%
Gastroesophageal Reflux Disease (a condition in which stomach contents leak backward from the stomach into the oesophagus): 1 person, 4.76%
Hypocalcaemia (levels of calcium in blood serum are abnormally low): 1 person, 4.76%

* Approximation only. Some reports may have incomplete information.

Do you take Abiraterone acetate and have Swallowing difficulty?

- Check whether Swallowing difficulty is associated with a drug or a condition
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously

Related studies:

Effectiveness of, long term effects of, and alternative drugs to Abiraterone acetate:

Abiraterone acetate (6,297 reports)

Browse all side effects of Abiraterone acetate:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all the drugs that are associated with Swallowing difficulty:

Swallowing difficulty (2,402 drugs)

Browse all the conditions that are associated with Swallowing difficulty:

Swallowing difficulty (3,352 conditions)

How the study uses the data?

The study uses data from the FDA. It is based on abiraterone acetate (the active ingredients of Abiraterone acetate) and Abiraterone acetate (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.